This page may have documents that can’t be read by screen reader software. For help with these documents, please call 1-800-975-6314.
You’ve undoubtedly read the recent news coverage of the widely reported success of several COVID-19 vaccines.
It’s been widely reported that two companies – Pfizer and Moderna – have reported positive preliminary results from large trial testing of COVID-19 vaccines. Pfizer received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) to begin vaccinating the public. Moderna has applied to the FDA for EUA to begin vaccinating the public.
Federal and state health officials will be working with the medical community on the rollout plan for the COVID-19 vaccine. Members should talk to their health care providers about when a vaccine will be available and any questions they might have about the vaccine.
Broad distribution of a coronavirus vaccine is considered months away at this time.
We will share more information as we receive updates about broader vaccine distribution and access. Initially, we anticipate that the cost of the vaccine will be paid by the government.
Blue Cross and Blue Shield of New Mexico, or plan sponsor (ASO groups), will cover administration of the vaccine as noted below:
In-network providers will be reimbursed for the administration fee based on contracted rates. Out-of-network (OON) providers will be reimbursed based on established OON reimbursement policy, which follows Medicare rates. We understand that the Pfizer and Moderna vaccines will require two doses.
There have been significant decreases in routine immunizations during the public health emergency. Please remind your clients to get all recommended immunizations and vaccines, including their flu vaccine, if they haven’t already.
Also continue to follow Centers for Disease Control and Prevention (CDC) guidelines, including:
We continue to monitor information provided by the CDC and other government and health officials. We’ll provide updates when we have them. For the latest information on COVID-19, we recommend visiting the CDC’s COVID-19 website.